Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - VARIAN MEDICAL SYSTEMS INC | exhibit322-2017q2.htm |
| EX-32.1 - EXHIBIT 32.1 - VARIAN MEDICAL SYSTEMS INC | exhibit321-2017q2.htm |
| EX-31.2 - EXHIBIT 31.2 - VARIAN MEDICAL SYSTEMS INC | exhibit312-2017q2.htm |
| EX-31.1 - EXHIBIT 31.1 - VARIAN MEDICAL SYSTEMS INC | exhibit311-2017q2.htm |
| 10-Q - 10-Q - VARIAN MEDICAL SYSTEMS INC | var10qq22017.htm |
Exhibit 15.1
May 9, 2017
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We are aware that our report dated May 9, 2017 on our review of interim financial information of Varian Medical Systems, Inc. for the three and six month periods ended March 31, 2017 and April 1, 2016 and included in the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2017 is incorporated by reference in its Registration Statements on Form S‑8 (No.333-188693, No.333-168444, No. 333-168443, No. 333-146176, No. 333-130001, No. 333-152903, No. 333-123778, No. 333-75531, No. 333-57006, No. 333-57008, No. 333-57010, and No. 333-161307).
Very truly yours,
/S/ PRICEWATERHOUSECOOPERS LLP
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP, 488 Almaden Boulevard, Suite 1800, San Jose, CA 95110
T: (408) 817 3700, F: (408) 817 5050, www.pwc.com/us